Excelex Biopolymers Profile
Key Indicators
- Authorised Capital ₹ 8.10 Cr
as on 16-07-2024
- Paid Up Capital ₹ 4.47 Cr
as on 16-07-2024
- Company Age 18 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 20.67 Cr
as on 16-07-2024
- Revenue 187.40%
(FY 2023)
- Profit 410.18%
(FY 2023)
- Ebitda 15.16%
(FY 2023)
- Net Worth 9.57%
(FY 2023)
- Total Assets -12.35%
(FY 2023)
About Excelex Biopolymers
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.10 Cr and a paid-up capital of Rs 4.47 Cr.
The company currently has active open charges totaling ₹20.67 Cr.
Chander Mohini, Pranay Arya, and Jatinder Arya serve as directors at the Company.
- CIN/LLPIN
U24119TG2006PTC068335
- Company No.
068335
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Sep 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Secunderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Excelex Biopolymers Private Limited offer?
Excelex Biopolymers Private Limited offers a wide range of products and services, including Flavours & Aromatics, Food Stabilizer, Textile, Dyeing & Finishing Chemical, Sizing Chemicals, Drilling & Boring Equipment, Drilling Equipment, Oil Field Chemical, Oil Refinery Chemical, Medical Consultants & Clinics, Health Care Service.
Who are the key members and board of directors at Excelex Biopolymers?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chander Mohini  | Director | 17-Dec-2012 | Current |
| Pranay Arya | Whole-Time Director | 26-Sep-2022 | Current |
| Jatinder Arya | Director | 27-Feb-2007 | Current |
Financial Performance and Corporate Structure Insights of Excelex Biopolymers.
Excelex Biopolymers Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 187.4% increase. The company also saw a substantial improvement in profitability, with a 410.18% increase in profit. The company's net worth moved up by a moderate rise of 9.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Excelex Biopolymers?
In 2022, Excelex Biopolymers had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
E P Industrial & Agro Products Private LimitedActive 30 years 10 monthsChander Mohini and Jatinder Arya are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 09 May 2022 | ₹1.50 Cr | Open |
Yes Bank Limited Creation Date: 26 Aug 2007 | ₹19.17 Cr | Open |
How Many Employees Work at Excelex Biopolymers?
Excelex Biopolymers has a workforce of 51 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Excelex Biopolymers, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Excelex Biopolymers's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
